Feedback / Questions
iduronicrin genleukocel-T (ISP-001) - Immusoft
https://www.prnewswire.com/news-releases/immusoft-receives-fda-fast-track-designation-for-isp-001-a-first-in-class-engineered-b-cell-therapy-for-mps-i-302589744.html
Oct 21, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next